Facebook
Twitter
Telegram
Report an ErrorBioVie Balance Sheet 2011-2024 | BIVI
Annual Balance Sheet BioVie
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-19.4 M | -18.5 M | - | 874 K | -340 K | 780 K | 29.9 K | -114 K | -267 K | -333 K | -506 K | - | - |
Long Term Debt |
42.5 K | 87.4 K | - | 62.5 K | - | 826 K | - | - | - | - | - | - | - |
Long Term Debt Current |
44.9 K | 38.9 K | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | 62.5 K | - | 826 K | 576 K | 1 | - | - | - | - | - |
Total Current Liabilities |
14.5 M | 4.17 M | 996 K | 23.5 M | 443 K | 1.24 M | 631 K | 803 K | 324 K | 161 K | - | - | - |
Total Liabilities |
19.8 M | 16.4 M | 996 K | 23.6 M | 443 K | 2.06 M | 1.21 M | 803 K | 324 K | 161 K | 15 K | - | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-301 M | -251 M | -225 M | -41 M | -7.26 M | -4.77 M | -2.34 M | -1 M | -572 K | -339 K | -17.5 K | - | - |
Total Assets |
35.1 M | 20.1 M | 6.05 M | 2.08 M | 2.57 M | 2.18 M | 2.36 M | 2.72 M | 269 K | 333 K | 506 K | - | - |
Cash and Cash Equivalents |
19.5 M | 18.6 M | 4.51 M | 37.2 K | 340 K | 45.8 K | 5.14 K | 124 K | 267 K | 333 K | 506 K | - | - |
Book Value |
15.3 M | 3.67 M | 5.05 M | -21.5 M | 2.13 M | 111 K | 1.16 M | 1.92 M | -54.1 K | 171 K | 491 K | - | - |
Total Shareholders Equity |
15.3 M | 3.67 M | 5.05 M | -21.5 M | 2.13 M | 111 K | 1.16 M | 1.92 M | -54.1 K | 171 K | 491 K | - | - |
All numbers in USD currency
Quarterly Balance Sheet BioVie
| 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
366 K | 30.2 K | 42.5 K | 54.5 K | 65.8 K | 76.8 K | 87.4 K | 97.8 K | - | - | - | 62.5 K | 62.5 K | 62.5 K | 62.5 K | 62.5 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 826 K | 826 K | 826 K | 576 K | 576 K | 576 K | 576 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
12.8 M | 16.2 M | 19.8 M | 23.5 M | 21.1 M | 16.9 M | 16.4 M | 16.2 M | 15.8 M | 1.74 M | 996 K | 996 K | 385 K | 266 K | 23.6 M | 23.6 M | - | 11.3 M | 443 K | 443 K | 105 K | 183 K | 2.06 M | 2.06 M | 1.46 M | 1.24 M | 1.21 M | 1.21 M | - | - | 803 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-329 M | -312 M | -301 M | -292 M | -277 M | -261 M | -251 M | -243 M | -236 M | -230 M | -225 M | -225 M | -90.4 M | -87.3 M | -41 M | -41 M | -21.5 M | -28.2 M | -7.26 M | -7.26 M | -5.76 M | -5.26 M | -4.77 M | -4.77 M | -3.5 M | -3 M | -2.34 M | -2.34 M | -1.71 M | -1.36 M | -1 M | -1.36 M | - | -572 K | -572 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
31.8 M | 23.8 M | 35.1 M | 45.2 M | 47.2 M | 22.9 M | 20.1 M | 26.2 M | 31.9 M | 22 M | 6.05 M | 6.05 M | 13.5 M | 14.9 M | 2.08 M | 2.08 M | 2.34 M | 2.61 M | 2.57 M | 2.57 M | 3.65 M | 4.21 M | 2.18 M | 2.18 M | 2.25 M | 2.32 M | 2.36 M | 2.36 M | 2.48 M | 2.54 M | 2.72 M | 2.54 M | 250 K | 266 K | 269 K | 269 K | 293 K | 318 K | 333 K | 333 K | 407 K | 446 K | 506 K | 506 K | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
30.4 M | 21.2 M | 19.5 M | 31.3 M | 45.7 M | 21.2 M | 18.6 M | 24.5 M | 30.4 M | 20.5 M | 4.51 M | 20.5 M | 37.2 K | 13.2 M | 11.9 M | 13.2 M | 3.11 K | 249 K | 3.11 K | 249 K | 1.63 M | 2.14 M | 1.63 M | 2.14 M | 1.82 K | 21.7 K | 1.82 K | 21.7 K | 4.52 K | 8.74 K | 4.52 K | 8.74 K | 250 K | 266 K | 250 K | 266 K | 288 K | 318 K | 288 K | 318 K | 407 K | 446 K | 407 K | 446 K | - | - | - | - | - | - | - | - |
Book Value |
18.9 M | 7.55 M | 15.3 M | 21.7 M | 26.1 M | 5.96 M | 3.67 M | 9.95 M | 16.1 M | 20.2 M | 5.05 M | 5.05 M | 13.1 M | 14.6 M | -21.5 M | -21.5 M | 2.34 M | -8.72 M | 2.13 M | 2.13 M | 3.54 M | 4.02 M | 111 K | 111 K | 791 K | 1.08 M | 1.16 M | 1.16 M | 2.48 M | 2.54 M | 1.92 M | 2.54 M | 250 K | 266 K | 269 K | 269 K | 293 K | 318 K | 333 K | 333 K | 407 K | 446 K | 506 K | 506 K | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
18.9 M | 7.55 M | 15.3 M | 21.7 M | 26.1 M | 5.96 M | 3.67 M | 9.95 M | 16.1 M | 20.2 M | 5.05 M | 20.2 M | 13.1 M | 14.6 M | 13.1 M | 14.6 M | -2.04 M | -8.72 M | 2.13 M | 2.13 M | 3.54 M | 4.02 M | 111 K | 111 K | 791 K | 1.08 M | 1.16 M | 1.16 M | 1.33 M | 1.58 M | 1.92 M | 1.58 M | -155 K | -107 K | -54.1 K | -54.1 K | 45.9 K | 115 K | 171 K | 171 K | 390 K | 437 K | 491 K | 491 K | - | - | - | - | - | - | - | - |
All numbers in USD currency